Contineum Therapeutics, Inc. ($CTNM)
Watkins Tim โ CMO & Head of Development
Shares
3,611
Price
$0.00
Total Value
$0.00
Nearby Earnings
Mar 5, 2026
EPS:Est: -0.50
Revenue:Est: $5.00M
Transaction Details
| Insider | Watkins Tim |
|---|---|
| Title | CMO & Head of Development |
| Transaction Date | Mar 2, 2026 |
| Expiration Date | Apr 27, 2035 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 2, 2026 |
| Shares Purchased | 3,611 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 249,167 |
| Derivative | Derivative |
| Accession Number | 0001437749-26-006421 |
| Document | View SEC Filing |